Lumexa Imaging (NASDAQ:LMRI) Shares Gap Up – Should You Buy?

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) shares gapped up prior to trading on Tuesday . The stock had previously closed at $6.77, but opened at $7.25. Lumexa Imaging shares last traded at $7.2710, with a volume of 465,230 shares traded.

Wall Street Analyst Weigh In

LMRI has been the subject of several research reports. Weiss Ratings began coverage on shares of Lumexa Imaging in a research report on Wednesday, May 13th. They set a “sell (e-)” rating for the company. Raymond James Financial raised Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective on the stock in a research note on Monday, February 9th. Finally, Barclays cut their price objective on Lumexa Imaging from $23.00 to $15.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $19.00.

Lumexa Imaging Stock Performance

The business has a fifty day moving average of $10.18.

Institutional Investors Weigh In On Lumexa Imaging

Several hedge funds and other institutional investors have recently added to or reduced their stakes in LMRI. T. Rowe Price Investment Management Inc. purchased a new stake in Lumexa Imaging in the 4th quarter worth approximately $37,139,000. Janus Henderson Group PLC bought a new position in Lumexa Imaging in the 4th quarter worth approximately $36,860,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Lumexa Imaging in the 4th quarter worth approximately $27,750,000. ArrowMark Colorado Holdings LLC bought a new position in Lumexa Imaging in the 4th quarter worth approximately $27,750,000. Finally, Invesco Ltd. bought a new position in Lumexa Imaging in the 4th quarter worth approximately $26,562,000.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).